CATALOGO DEI PRODOTTI DELLA RICERCA

CAMPOSTRINI, Natascia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.280
EU - Europa 3.852
AS - Asia 2.795
SA - Sud America 419
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 60
OC - Oceania 7
Totale 12.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.131
RU - Federazione Russa 1.444
SG - Singapore 1.079
GB - Regno Unito 901
CN - Cina 874
BR - Brasile 333
VN - Vietnam 257
SE - Svezia 252
IT - Italia 244
HK - Hong Kong 238
FR - Francia 228
DE - Germania 203
IE - Irlanda 185
FI - Finlandia 183
KR - Corea 79
CA - Canada 76
UA - Ucraina 63
JP - Giappone 61
IN - India 45
AR - Argentina 35
NL - Olanda 30
TR - Turchia 28
BD - Bangladesh 26
BE - Belgio 24
ES - Italia 22
MX - Messico 20
IQ - Iraq 18
NG - Nigeria 17
PL - Polonia 17
ZA - Sudafrica 14
ID - Indonesia 12
EC - Ecuador 11
PK - Pakistan 10
CR - Costa Rica 9
HN - Honduras 9
IR - Iran 9
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CO - Colombia 7
IL - Israele 7
MA - Marocco 7
UY - Uruguay 7
CW - ???statistics.table.value.countryCode.CW??? 6
EG - Egitto 6
GT - Guatemala 6
LT - Lituania 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
MY - Malesia 5
PH - Filippine 5
PR - Porto Rico 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
HR - Croazia 4
KZ - Kazakistan 4
NP - Nepal 4
SI - Slovenia 4
TN - Tunisia 4
DK - Danimarca 3
GR - Grecia 3
JM - Giamaica 3
LV - Lettonia 3
MD - Moldavia 3
PE - Perù 3
PY - Paraguay 3
SA - Arabia Saudita 3
SV - El Salvador 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EU - Europa 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
OM - Oman 2
RO - Romania 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
EE - Estonia 1
GD - Grenada 1
GP - Guadalupe 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 12.410
Salva come PNG Salva come JPEG
Città #
Southend 733
Singapore 616
Ashburn 578
Chandler 513
Jacksonville 481
Moscow 478
San Jose 471
Woodbridge 340
Dallas 314
Ann Arbor 234
Hong Kong 233
Houston 199
Dublin 184
Beijing 166
Council Bluffs 160
Verona 125
New York 112
The Dalles 104
Ho Chi Minh City 95
Princeton 78
Lawrence 77
Los Angeles 77
Wilmington 69
Lancaster 64
Nanjing 61
Santa Clara 61
Jinan 59
Tokyo 59
Hanoi 52
Munich 48
São Paulo 44
Boardman 41
Shenyang 34
Buffalo 33
Columbus 31
Helsinki 31
Montreal 26
Tianjin 26
Nanchang 25
Redondo Beach 24
Orem 23
Brooklyn 22
Brussels 22
Hebei 22
Sindelfingen 21
Changsha 20
Hangzhou 20
Jiaxing 20
Haikou 19
Milan 19
Toronto 19
Zhengzhou 19
Guangzhou 18
Norwalk 17
Chennai 16
Ningbo 16
Atlanta 15
London 15
Taizhou 15
Abuja 14
Denver 14
Seattle 14
Turku 14
San Francisco 13
Taiyuan 13
Warsaw 13
Amsterdam 12
Bologna 12
Redmond 12
Rio de Janeiro 12
Chicago 11
Poplar 11
Stockholm 11
Boston 10
Lanzhou 10
Manchester 10
Fairfield 9
Haiphong 9
San Mateo 9
Shanghai 9
Brasília 8
Dhaka 8
Fuzhou 8
Hải Dương 8
Johannesburg 8
Ankara 7
Dearborn 7
Madrid 7
Miami 7
Montevideo 7
Phoenix 7
Rome 7
Washington 7
Ardabil 6
Baghdad 6
Barnet 6
Belo Horizonte 6
Can Tho 6
Charlotte 6
Falls Church 6
Totale 7.894
Salva come PNG Salva come JPEG
Nome #
MOLECULARLY IMPRINTED NANOPARTICLES FOR HEPCIDIN CAPTURE: A SYNTHETIC ALTERNATIVE TO NATURAL ANTIBODIES 241
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 240
A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. 233
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 228
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 228
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 220
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 217
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 215
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 212
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 211
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 207
The proteome: anno Domini 2002 206
A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism 204
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 202
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 202
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 200
Altered paraoxonase expression in patients with genetic haemochromatosis. 196
High-protein goat's milk diet identified through newborn screening: clinical warning of a potentially dangerous dietetic practice 194
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 193
Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cells 192
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing. 190
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 187
“Proteomics approaches for studying chemoresistance in cancer” 184
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 180
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. 178
"Quantitative Proteomics" 178
“Pre-fractionation for Hidden Proteome” 177
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 174
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 173
“Application of Partial Least Squares Discriminant Analysis and variable selection procedures: a 2D-PAGE Proteomic-Based Study” 172
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience 169
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy 169
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 168
TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. 168
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 166
Serum Hepcidin in Inflammatory Bowel Diseases: biological and clinical significance. 166
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 163
Association ofHFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. 162
Does TMPRSS6 RS855791 Polymorphism Contribute to Iron Deficiency in Treated Celiac Disease? 162
Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: a case report. 160
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity 160
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 156
Hepcidin levels and their determinants in different types of myelodysplastic syndromes. 152
Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin 152
“Numerical approaches for quantitative analysis of 2D map: a review of commercial software and of “home-made” systems” 150
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 150
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. 149
Reduced serum hepcidin levels in patients with chronic hepatitis C 146
Proteomic analysis of S-nitrosylated proteins in Arabidopsis during the disease resistance response 145
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 142
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 142
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 138
Quantitative proteomics: a review of different methodologies. 133
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 132
Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. 131
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. 130
PON1 activity and coagulation biomarkers: no association with thrombin generation parameters but an inverse correlation with D-dimer plasma concentration 128
Study of proteomic changes associated with healthy and tumoral murine samples in neuroblastoma by principal component analysis and classification methods. 127
Proteomic analysis of an orthotopic neuroblastoma xenograft animal model. 126
Formation of truncated proteins and high-molecular-mass aggregates upon soft illumination of photosynthetic proteins. 125
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material 122
Iron deficiency in the elderly population, revisited in the hepcidin era. 120
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo 119
Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study. 118
Omics | quantitative proteomics 116
Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. 113
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 112
Two-dimensional mapping as a tool for classification of green coffee bean species. 111
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease 111
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 111
Hepcidin levels in chronic hemodialysis patients: a critical evaluation. 109
Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. 108
Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) Patient 108
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 106
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization 101
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 99
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA) 97
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. 92
Totale 12.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.866
article - articoli 31.078
book - libri 0
conference - conferenze 8.690
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.098
Totale 83.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022357 0 0 0 65 20 16 6 27 20 15 62 126
2022/20231.345 90 142 129 216 146 317 23 79 156 4 27 16
2023/2024603 24 48 39 51 76 126 14 35 4 11 120 55
2024/20251.497 67 103 63 274 62 68 60 46 233 84 125 312
2025/20264.733 344 283 350 866 1.207 286 454 235 295 240 47 126
2026/2027814 69 148 170 427 0 0 0 0 0 0 0 0
Totale 12.474